Childhood antecedents and risk for adult mental disorders

Annual Review of Psychology

Volumn 66, Issue , 2015, Pages 459-485

  Pine, Daniel S ^a   Fox, Nathan A ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Amygdala; Anxiety; Developmental psychopathology; Prefrontal cortex

Indexed keywords

ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD DEVELOPMENT; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DEPRESSIVE DISORDER; GENETICS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOTIC DISORDERS; TEMPERAMENT; THERAPY;

ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD DEVELOPMENT; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DEPRESSIVE DISORDER; GENETICS; HUMANS; PHYSIOLOGY; PHYSIOPATHOLOGY; PSYCHOTIC DISORDERS; TEMPERAMENT; THERAPY;

EID: 84964284812     PISSN: 00664308     EISSN: 15452085     Source Type: Book Series    
DOI: 10.1146/annurev-psych-010814-015038     Document Type: Article

References (94)

1. Alexopoulos GS, Kelly RE. 2009. Research advances in geriatric depression. World Psychiatry 8:140-49
2. Am. Psychiatr. Assoc. 2013. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ. 5th ed.
3. Angold A, Costello EJ, Erkanli A, Worthman CM. 1999. Pubertal changes in hormone levels and depression in girls. Psychol. Med. 29:1043-53
4. Auerbach BD, Osterweil EK, Bear MF. 2011. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480:63-68
5. Bacanu SA, Kendler KS. 2013. Extracting actionable information from genome scans. Genet. Epidemiol. 37:48-59
6. Bar-Haim Y, Lamy D, Pergamin L, Bakermans-Kranenburg MJ, van IJzendoorn MH. 2007. Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study. Psychol. Bull. 133:1-24
7. Barker TV, Reeb-Sutherland BC, Fox NA. 2014. Individual differences in fear potentiated startle in behav-iorally inhibited children. Dev. Psychobiol. 56:133-41
8. Beard C, Sawyer AT, Hofmann SG. 2012. Efficacy of attention bias modification using threat and appetitive stimuli: a meta-analytic review. Behav. Ther. 43:724-40
9. Bilder RM, Volavka J, Lachman HM, Grace AA. 2004. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29:1943-61
10. Blair J, Mithcell D, Blair K. 2005. The Psychopath: Emotion and the Brain. Oxford, UK: Blackwell Publ.
11. Bouton ME. 2002. Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biol. Psychiatry 52:976-86
12. Britton JC, Bar-Haim Y, Clementi MA, Sankin LS, Chen G, et al. 2013a. Training-associated changes and stability of attention bias in youth: implications for attention bias modification treatment for pediatric anxiety. Dev. Cogn. Neurosci. 4:52-64
13. Britton JC, Grillon C, Lissek S, Norcross MA, Szuhany KL, et al. 2013b. Response to learned threat: an fMRI study in adolescent and adult anxiety. Am. J. Psychiatry 170:1195-204
14. Carter CS, Barch DM. 2007. Cognitive neuroscience-based approachesto measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr. Bull. 33:1131-37
15. Carter CS, Barch DM. 2012. Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: biomarkers recommended for further development. Schizophr. Bull. 38:26-33
16. Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW, et al. 2011. Cognitive Neuroscience Treatment ResearchtoImprove Cognition in Schizophrenia II: developing imaging biomarkersto enhance treatment development for schizophrenia and related disorders. Biol. Psychiatry 70:7-12
17. Casey BJ, Pattwell SS, Glatt CE, Lee FS. 2013. Treating the developing brain: implications from human imaging and mouse genetics. Annu. Rev. Med. 64:427-39
18. Castellanos FX, Tannock R. 2002. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 3:617-28
19. Church SM, Cotter D, Bramon E, Murray RM. 2002. Does schizophrenia result from developmental or degenerative processes? J. Neural Transm. Suppl. 63:129-47
20. Cicchetti D. 2014. Illustrative developmental psychopathology perspectives on precursors and pathways to personality disorder: commentary on the special issue. J. Personal. Disord. 28:172-79
21. Clauss JA, Blackford JU. 2012. Behavioral inhibition and risk for developing social anxiety disorder: a meta-analytic study. J. Am. Acad. Child Adolesc. Psychiatry 51:1066-75. e1
22. Coe BP, Girirajan S, Eichler EE. 2012. The genetic variability and commonality of neurodevelopmental disease. Am. J. Med. Genet. C Semin. Med. Genet. 160C:118-29
23. Collins PY, Patel V, Joestl SS, March D, Insel TR, et al. 2011. Grand challenges in global mental health. Nature 475:27-30
24. Copeland WE, Shanahan L, Costello EJ, Angold A. 2009. Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch. Gen. Psychiatry 66:764-72
25. Costello EJ, Egger HL, Angold A. 2005. The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child Adolesc. Psychiatr. Clin. N. Am. 14:631-48, vii
26. Costello EJ, Pine DS, Hammen C, March JS, Plotsky PM, et al. 2002. Development and natural history of mood disorders. Biol. Psychiatry 52:529-42
27. Craske MG, Wolitzky-Taylor KB, Mineka S, Zinbarg R, Waters AM, et al. 2012. Elevated responding to safe conditions as a specific risk factor for anxiety versus depressive disorders: evidence from a longitudinal investigation. J. Abnorm. Psychol. 121:315-24
28. Etkin A, Prater KE, Hoeft F, Menon V, Schatzberg AF. 2010. Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder. Am. J. Psychiatry 167:545-54
29. Fox NA, Henderson HA, Marshall PJ, Nichols KE, Ghera MM. 2005. Behavioral inhibition: linking biology and behavior within a developmental framework. Annu. Rev. Psychol. 56:235-62
30. Gejman PV, Sanders AR, Kendler KS. 2011. Genetics of schizophrenia: new findings and challenges. Annu. Rev. Genomics Hum. Genet. 12:121-44
31. Graham BM, Milad MR. 2011. The studyoffear extinction: implications for anxiety disorders. Am. J. Psychiatry 168:415-23
32. Grillon C, Warner V, Hille J, Merikangas KR, Bruder GE, et al. 2005. Families at high and low risk for depression: a three-generation startle study. Biol. Psychiatry 57:953-60
33. Hakamata Y, Lissek S, Bar-Haim Y, Britton JC, Fox NA, et al. 2010. Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol. Psychiatry 68:982-90
34. Han K, Holder JL Jr, Schaaf CP, Lu H, Chen H, et al. 2013. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 503:72-77
35. Harvey PD, Heaton RK, Carpenter WT Jr, Green MF, Gold JM, Schoenbaum M. 2012. Diagnosis of schizophrenia: consistency across information sources and stability of the condition. Schizophr. Res. 140:9-14
36. Hayward C, Sanborn K. 2002. Puberty and the emergence of gender differences in psychopathology. J. Adolesc. Health 30:49-58
37. Hettema JM, Neale MC, Kendler KS. 2001. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 158:1568-78
38. Hoeft F, Lightbody AA, Hazlett HC, Patnaik S, Piven J, Reiss AL. 2008. Morphometric spatial patterns differentiating boys with fragile X syndrome, typically developing boys, and developmentally delayed boys aged 1 to 3 years. Arch. Gen. Psychiatry 65:1087-97
39. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, et al. 2010. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167:748-51
40. Insel TR. 2009. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch. Gen. Psychiatry 66:128-33
41. Jaeggi SM, Buschkuehl M, Shah P, Jonides J. 2014. The role of individual differences in cognitive training and transfer. Mem. Cogn. 42:464-80
42. Jarcho JM, Fox NA, Pine DS, Etkin A, Leibenluft E, et al. 2013. The neural correlates of emotion-based cognitive control in adults with early childhood behavioral inhibition. Biol. Psychol. 92:306-14
43. Jonas RK, Montojo CA, Bearden CE. 2014. The 22q11. 2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan. Biol. Psychiatry 75:351-60
44. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62:593-602
45. Klin A, Jones W, Schultz R, Volkmar F, Cohen D. 2002. Defining and quantifying the social phenotype in autism. Am. J. Psychiatry 159:895-908
46. Klin A, Lin DJ, Gorrindo P, Ramsay G, Jones W. 2009. Two-year-olds with autism orient to non-social contingencies rather than biological motion. Nature 459:257-61
47. Kotov R, Leong SH, Mojtabai R, Erlanger AC, Fochtmann LJ, et al. 2013. Boundaries of schizoaffective disorder: revisiting Kraepelin. JAMA Psychiatry 70:1276-86
48. Lahat A, Lamm C, Chronis-Tuscano A, Pine DS, Henderson HA, Fox NA. 2014. Early behavioral inhibition and increased error monitoring predict later social phobia symptoms in childhood. J. Am. Acad. Child Adolesc. Psychiatry 53:447-55
49. LaSalle JM, Powell WT, Yasui DH. 2013. Epigenetic layers and players underlying neurodevelopment. Trends Neurosci. 36:460-70
50. Lau JY, Britton JC, Nelson EE, Angold A, Ernst M, et al. 2011. Distinct neural signatures of threat learning in adolescents and adults. Proc. Natl. Acad. Sci. USA 108:4500-5
51. Lewis-Morrarty E, Degnan KA, Chronis-Tuscano A, Rubin KH, Cheah CS, et al. 2012. Maternal over-control moderates the association between early childhood behavioral inhibition and adolescent social anxiety symptoms. J. Abnorm. Child Psychol. 40:1363-73
52. Lissek S, Pine DS, Grillon C. 2006. The strong situation: a potential impediment to studying the psychobiology and pharmacology of anxiety disorders. Biol. Psychol. 72:265-70
53. Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, et al. 2005. Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav. Res. Ther. 43:1391-424
54. Lissek S, Rabin S, Heller RE, Lukenbaugh D, Geraci M, et al. 2010. Overgeneralization of conditioned fear as a pathogenic marker of panic disorder. Am. J. Psychiatry 167:47-55
55. Lord C, Risi S, DiLavore PS, Shulman C, Thurm A, Pickles A. 2006. Autism from 2 to 9 years of age. Arch. Gen. Psychiatry 63:694-701
56. McDermott JM, Perez-Edgar K, Henderson HA, Chronis-Tuscano A, Pine DS, Fox NA. 2009. A history of childhood behavioral inhibition and enhanced response monitoring in adolescence are linked to clinical anxiety. Biol. Psychiatry 65:445-48
57. Meaney MJ. 2001. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 24:1161-92
58. Moffitt TE, Caspi A. 2001. Childhood predictors differentiate life-course persistent and adolescence-limited antisocial pathways among males and females. Dev. Psychopathol. 13:355-75
59. Moser JS, Moran TP, Schroder HS, Donnellan MB, Yeung N. 2013. On the relationship between anxiety and error monitoring: a meta-analysis and conceptual framework. Front. Hum. Neurosci. 7:466
60. Murdoch JD, State MW. 2013. Recent developments in the genetics of autism spectrum disorders. Curr. Opin. Genet. Dev. 23:310-15
61. Nigg JT. 2007. What Causes ADHD? New York: Guilford
62. Nigg JT, Casey BJ. 2005. An integrative theory of attention-deficit/hyperactivity disorder based on the cognitive and affective neurosciences. Dev. Psychopathol. 17:785-806
63. Nuechterlein KH, Subotnik KL, Ventura J, Green MF, Gretchen-Doorly D, Asarnow RF. 2012. The puzzle of schizophrenia: tracking the core role of cognitive deficits. Dev. Psychopathol. 24:529-36
64. Owen MJ, Craddock N, O'Donovan MC. 2010. Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Arch. Gen. Psychiatry 67:667-73
65. Ozonoff S, Cook I, Coon H, Dawson G, Joseph RM, et al. 2004. Performance on Cambridge Neuropsy-chological Test Automated Battery subtests sensitive to frontal lobe function in people with autistic disorder: evidence from the Collaborative Programs of Excellence in Autism network. J. Autism Dev. Disord. 34:139-50
66. Parker KJ, Buckmaster CL, Sundlass K, Schatzberg AF, Lyons DM. 2006. Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primates. Proc. Natl. Acad. Sci. USA 103:3000-5
67. Pine DS, Cohen E, Cohen P, Brook J. 1999. Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder? Am. J. Psychiatry 156:133-35
68. Pine DS, Cohen JA. 2002. Trauma in children and adolescents: risk and treatment of psychiatric sequelae. Biol. Psychiatry 51:519-31
69. Pine DS, Cohen P, Gurley D, Brook J, Ma Y. 1998. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch. Gen. Psychiatry 55:56-64
70. Pine DS, Helfinstein SM, Bar-Haim Y, Nelson E, Fox NA. 2009. Challenges in developing novel treatments for childhood disorders: lessons from research on anxiety. Neuropsychopharmacology 34:213-28
71. Quirk GJ, Mueller D. 2008. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33:56-72
72. Rapee RM. 2013. The preventative effects of a brief, early intervention for preschool-aged children at risk for internalising: follow-up into middle adolescence. J. Child Psychol. Psychiatry 54:780-88
73. Reeb-Sutherland BC, Helfinstein SM, Degnan KA, Perez-Edgar K, Henderson HA, et al. 2009. Startle response in behaviorally inhibited adolescents with a lifetime occurrence of anxiety disorders. J. Am. Acad. Child Adolesc. Psychiatry 48:610-17
74. Rosenbaum JF, Biederman J, Hirshfeld-Becker DR, Kagan J, Snidman N, et al. 2000. A controlled study of behavioral inhibition in children of parents with panic disorder and depression. Am. J. Psychiatry 157:2002-10
75. Rutter M. 2002. The interplay of nature, nurture, and developmental influences: the challenge ahead for mental health. Arch. Gen. Psychiatry 59:996-1000
76. Rutter M. 2005. Autism research: lessons from the past and prospects for the future. J. Autism Dev. Disord. 35:241-57
77. Rutter M, Kim-Cohen J, Maughan B. 2006. Continuities and discontinuities in psychopathology between childhood and adult life. J. Child Psychol. Psychiatry 47:276-95
78. Salum GA, Mogg K, Bradley BP, Gadelha A, Pan P, et al. 2012. Threat bias in attention orienting: evidence of specificity in a large community-based study. Psychol. Med. 43:733-45
79. Shatz CJ. 2009. MHC class I: an unexpected role in neuronal plasticity. Neuron 64:40-45
80. Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R, et al. 2013. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503:267-71
81. Shechner T, Britton JC, Perez-Edgar K, Bar-Haim Y, Ernst M, et al. 2012. Attention biases, anxiety, and development: toward or away from threats or rewards? Depress. Anxiety 29:282-94
82. Shechner T, Rimon-Chakir A, Britton JC, Lotan D, Apter A, et al. 2014. Attention bias modification treatment augmenting effects on cognitive behavioral therapy in children with anxiety: randomized controlled trial. J. Am. Acad. Child Adolesc. Psychiatry 53:61-71
83. State MW, Levitt P. 2011. The conundrums of understanding genetic risks for autism spectrum disorders. Nat. Neurosci. 14:1499-506
84. State MW, Sestan N. 2012. Neuroscience. The emerging biology of autism spectrum disorders. Science 337:1301-3
85. Torpey DC, Hajcak G, Kim J, Kujawa AJ, Dyson MW, et al. 2013. Error-related brain activity in young children: associations with parental anxiety and child temperamental negative emotionality. J. Child Psychol. Psychiatry 54:854-62
86. Van Bockstaele B, Verschuere B, Tibboel H, De Houwer J, Crombez G, Koster EH. 2013. A review of current evidence for the causal impact of attentional bias on fear and anxiety. Psychol. Bull. 140:682-721
87. van der Werf M, Hanssen M, Kohler S, Verkaaik M, Verhey FR, et al. 2014. Systematic review and collaborative recalculation of 133, 693 incident cases of schizophrenia. Psychol. Med. 44:9-16
88. van Os J. 2013. The dynamics of subthreshold psychopathology: implications for diagnosis and treatment. Am. J. Psychiatry 170:695-98
89. van Os J, Kenis G, Rutten BP. 2010. The environment and schizophrenia. Nature 468:203-12
90. Veenstra-Vander Weele J, Blakely RD. 2012. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology 37:196-212
91. Wald I, Degnan KA, Gorodetsky E, Charney DS, Fox NA, et al. 2013. Attention to threats and combat-related posttraumatic stress symptoms: prospective associations and moderation by the serotonin transporter gene. JAMA Psychiatry 70:401-8
92. Walters JT, Rujescu D, Franke B, Giegling I, Vasquez AA, et al. 2013. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up. Am. J. Psychiatry 170:877-85
93. Wilson M. 1993. DSM-III and the transformation of American psychiatry: a history. Am. J. Psychiatry 150:399-410
94. Wolff JJ, Gu H, Gerig G, Elison JT, Styner M, et al. 2012. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am. J. Psychiatry 169:589-600